You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT JAMA
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 258 No. 18, November 13, 1987 TABLE OF CONTENTS
  JAMA
  •  Online Features
  Brief Reports
 This Article
 •References
 •Full text PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Contact me when this article is cited
 Related Content
 •Similar articles in JAMA
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati
What's this?

A Comparative Trial of Clotrimazole Troches and Oral Nystatin Suspension in Recipients of Renal Transplants

Use in Prophylaxis of Oropharyngeal Candidiasis

Myles E. Gombert, MD; Lorraine duBouchet; Taryn M. Aulicino; Khalid M. H. Butt, MD

JAMA. 1987;258(18):2553-2555.


Abstract

An open study designed to compare the effectiveness and safety of clotrimazole troches with nystatin oral suspension in the prevention of oropharyngeal candidiasis was conducted. This study was performed as the troche form of clotrimazole was easier to administer and less costly than nystatin oral suspension. Sixty assessable patients were randomized to receive either clotrimazole troches (n = 32) or nystatin oral suspension (n = 28) for a 60-day period after receiving a renal allograft. The two groups were comparable in age, sex, type of transplant, and amount of immunosuppression. Both regimens were 100% effective in preventing the development of thrush in the patients studied. Adverse effects were infrequently seen in either group (one case of mild nausea in the clotrimazole group and three cases in the nystatin group). One patient chose to withdraw from the clotrimazole group, and eight patients withdrew from the nystatin group before completing 60 days of therapy (P =.002). Reasons given for withdrawal were the unpleasant taste of the drugs, or an inability to comply with the protocol. The cost of clotrimazole troches in the prophylactic doses given in this study was approximately one tenth that of nystatin oral suspension. Clotrimazole troches are effective, less expensive, and easier to self-administer than nystatin oral suspension.

(JAMA 1987;258:2553-2555)



Author Affiliations

From the Division of Infectious Diseases, Department of Medicine (Dr Gombert and Mss duBouchet and Aulicino), and the Division of Transplantation, Department of Surgery (Dr Butt), State University of New York, Health Science Center at Brooklyn.


Footnotes

Reprint requests to Box 56, SUNY Health Science Center at Brooklyn, 450 Clardson Ave, Brooklyn, NY 11203 (Dr Gombert).



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Heart Transplantation
Bethea et al.
Card Surg Adult 2003;2:1427-1460.
FULL TEXT  

Oral Candidal Infections and Antimycotics
Ellepola and Samaranayake
CROBM 2000;11:172-198.
ABSTRACT | FULL TEXT  

Preventive Health Care for Adults With HIV Infection
Jewett and Hecht
JAMA 1993;269:1144-1153.
ABSTRACT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1987 American Medical Association. All Rights Reserved.